Prev MonthPrev Month Next MonthNext Month
MANP Pharma Dinner, 09/20/2022 Southaven MS
Mesquite Chop House
5960 Getwell Rd
Southaven, MS 38672
(662) 890-2467

View additional information
Tuesday, September 20, 2022, 6:00 PM - 8:00 PM CDT
Category: Events

09/20/2022 Southaven, MS, Mesquite Chophouse 

Eli Lilly’s much-anticipated Mounjaro™ (trizepatide) 

There’s a new option on the market for patients seeking treatment with a GLP-1-type drug: Eli Lilly’s much-anticipated Mounjaro™ (trizepatide) was approved by the FDA in May 2022 for those with type 2 diabetes. As a dual GIP and GLP-1 receptor agonist, Mounjaro™ is the first drug of its kind and has been touted as a game changer by many medical professionals in the broader field of endocrinology and metabolic health.
RSVP to Kent Hawkins

Contact: RSVP to Kent Hawkins at [email protected]